In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany - PubMed (original) (raw)
In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany
R R Reinert et al. Antimicrob Agents Chemother. 1998 Jun.
Abstract
The comparative in vitro activity of HMR 3004 and HMR 3647, new ketolide antibiotics, was tested by a standard agar dilution technique against 221 pneumococcal strains, including isolates with intermediate levels of resistance to penicillin and erythromycin-resistant isolates. The ketolides were more active than other macrolides and showed excellent activity against erythromycin-resistant strains. All the strains were inhibited by < or = 2 micrograms of HMR 3004/ml or by < or = 0.5 microgram of HMR 3647/ml.
References
- Appelbaum P C. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992;15:77–83. -PubMed
- Barry A L, Brown S D, Fuchs P C. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1997. Antipneumococcal activity of a ketolide (HMR 3647) and seven related drugs in vitro, abstr. F-107; p. 164.
- Barry A, Fuchs P, Brown S. In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae. Eur J Clin Microbiol Infect Dis. 1997;16:767–769. -PubMed
- Doern G, Brueggemann A, Holley H P, Rauch A M. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother. 1996;40:1208–1213. -PMC -PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical